Mesoblast (MESO) Posts Q1 Loss of 5c/Share

November 14, 2016 4:59 PM EST
Get Alerts MESO Hot Sheet
Trade MESO Now!
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

Mesoblast (NASDAQ: MESO) reported Q1 EPS of ($0.05), $0.30 better than the analyst estimate of ($0.35). Revenue for the quarter came in at $395 thousand versus the consensus estimate of $3.69 thousand.

In line with previous guidance, the Company implemented operational streamlining measures during the quarter while achieving, and continuing to maintain progress towards, key milestones in its Tier 1 clinical programs.

For earnings history and earnings-related data on Mesoblast (MESO) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment